Contact
Please use this form to send email to PR contact of this press release:
First Patent Enrolled in BioVie Phase 2a Clinical Trial of BIV201 for Ascites
TO:
Please use this form to send email to PR contact of this press release:
First Patent Enrolled in BioVie Phase 2a Clinical Trial of BIV201 for Ascites
TO: